Lonza Group | LONN - Ebit

Lonza Group reported CHF699M in EBIT for its second fiscal semester of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Ebit Change
Akzo Nobel AKZA:NA EUR 126M 26M
Alcon AG ALC:SW USD 24M 198M
AstraZeneca AZN:LN USD 1.84B 429M
BASF BAS:GR EUR -220000000 2.01B
Bayer BAYN:GR EUR 3.94B 2.59B
Covestro 1COV:GR EUR -695000000 761M
Fresenius FRE:GR EUR 1.05B 207M
Fresenius Medical Care FME:GR EUR 445M 136.5M
Genmab GEN:DC DKK 2.66B 734M
Givaudan GIVN:VX CHF 478M 147M
GlaxoSmithKline GSK:LN GBP 1.44B 967M
GN Store Nord GN:DC DKK 463M 52M
Hikma Pharmaceutical HIK:LN USD 302M 46M
Johnson Matthey JMAT:LN GBP 220M 33M
Merck MRK:GR EUR 1.16B 189M
Novartis NOVN:VX USD 3.1B 228M
Philips PHIA:NA EUR 548M 443M
Roche Holding ROG:VX 8.49B 3.05B
Smith & Nephew PLC SN/:LN 335M 57M
William Demant Holding WDH:DC DKK 1.57B 38M